What are the typical symptoms of polycythemia vera?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Polycythemia Vera Symptoms

Polycythemia vera presents with a characteristic constellation of symptoms including aquagenic pruritus (itching after bathing), erythromelalgia (burning pain in hands/feet), microvascular disturbances (headache, visual changes, lightheadedness), splenomegaly, and constitutional symptoms, alongside laboratory findings of elevated hematocrit, thrombocytosis, and leukocytosis. 1

Primary Clinical Manifestations

Microvascular Disturbances

These result from platelet-endothelial interactions causing transient occlusive phenomena and include 1:

  • Headache and lightheadedness
  • Transient neurologic or ocular disturbances (visual changes occur in 14% of patients) 2
  • Tinnitus
  • Atypical chest discomfort
  • Paresthesias

Erythromelalgia

This highly characteristic symptom occurs in approximately 3-5.3% of PV patients 1, 2. It manifests as:

  • Painful, burning sensation in feet or hands
  • Associated erythema and warmth
  • Responds promptly (within hours) to low-dose aspirin (81 mg/day) 1

The pathogenesis involves platelet-mediated endothelial injury with transient thrombotic occlusion by platelet aggregates 1.

Aquagenic Pruritus

This is one of the most debilitating symptoms 1:

  • Occurs in 33-48% of patients either at diagnosis or later 1, 2
  • Characteristically exacerbated by hot baths or showers 1
  • May cause sleep deprivation and interference with social/physical activities 1
  • Can be the most agonizing aspect of the disease 1

Splenomegaly

  • Present in 36% of patients 2
  • May cause abdominal discomfort 2

Constitutional Symptoms

Patients commonly experience 3, 4:

  • Fatigue
  • Bone pain
  • Night sweats
  • Weight loss

Laboratory and Hematologic Features

Blood Count Abnormalities

The diagnostic hallmark is erythrocytosis, but other cytopenias are common 1:

  • Elevated hemoglobin/hematocrit (required for diagnosis: >16.5 g/dL in men, >16.0 g/dL in women) 2
  • Thrombocytosis in 53% of patients 2
  • Leukocytosis in 49% of patients 2
  • Microcytosis from iron deficiency (may occur due to repeated phlebotomy or occult bleeding) 1

PV-Related Features That Should Prompt Diagnostic Consideration

The diagnosis should be suspected when any of these features accompany borderline-high hematocrit 1:

  • Thrombocytosis
  • Leukocytosis
  • Microcytosis from iron deficiency
  • Splenomegaly
  • Aquagenic pruritus
  • Unusual thrombosis including Budd-Chiari syndrome 1
  • Erythromelalgia

Thrombotic and Hemorrhagic Complications

Thrombosis Risk

PV carries significant thrombotic risk 2, 3:

  • Arterial thrombosis occurs in 16% prior to or at diagnosis 2
  • Venous thrombotic events in 7% 2
  • Venous thrombosis can involve unusual sites, particularly splanchnic veins 2
  • 20-year thrombosis risk approximately 26% 3

Bleeding Risk

  • Increased bleeding risk, especially with extreme thrombocytosis (platelet count ≥1000 × 10⁹/L) 2
  • Acquired von Willebrand disease can occur with extreme thrombocytosis 2

Important Clinical Pitfalls

Diagnostic Considerations

  1. Iron deficiency can mask the diagnosis by lowering hemoglobin/hematocrit into the normal range despite underlying PV 1
  2. Documented increase in hemoglobin/hematocrit above baseline for an individual patient warrants investigation, even if values remain within the reference range 1
  3. Comorbid conditions causing hypoxia (e.g., chronic lung disease) can coexist with PV and complicate diagnosis 1

Symptom Management Nuances

  • Pruritus treatment is challenging: antihistamines have unpredictable responses; paroxetine (selective serotonin reuptake inhibitor) shows >80% response rate 1; interferon-α reduces pruritus in up to 81% of patients 1
  • Iron replacement for pruritus is discouraged despite some correlation with iron deficiency, as it has not been consistently effective 1
  • Erythromelalgia requires aspirin as first-line, but cytoreductive therapy may be necessary if aspirin fails 1

Long-Term Disease Manifestations

Patients face risks of disease transformation 2, 3:

  • 12.7% develop myelofibrosis 2
  • 6.8% develop acute myeloid leukemia 2
  • 20-year risk for post-PV myelofibrosis approximately 16% 3
  • 20-year risk for acute leukemia approximately 4% 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.